NuCana (NCNA) Shares Outstanding (Diluted Average) (2021 - 2023)
NuCana's (NCNA) quarterly Shares Outstanding (Diluted Average) came in at $312840.8 in Q2 2023, up 3.51% year-on-year from $302235.4 in Q2 2022, and up 3.51% quarter-over-quarter from $302235.4 in Q2 2022.
NuCana (NCNA) Shares Outstanding (Diluted Average) (2021 - 2023) Analysis & Trends
NuCana has disclosed Shares Outstanding (Diluted Average) across 3 years of filings, most recently posting $312840.8 for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 810.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 118.76 Bn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 92.44 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 312,840.79 |
| Jun 30, 2022 | 302,235.41 |
| Jun 30, 2021 | 503,182.17 |